Exercise and Patient Education Compared With Usual Care in Patients With Hip Dysplasia

Summary

This effectiveness trial will investigate if patients with hip dysplasia randomised to exercise and patient education have a different mean change in self-reported pain measured by the Copenhagen Hip and Groin Outcome Score (HAGOS) compared with those randomised to usual care over a six-month follow-up period.

Participating patients will be allocated to either exercise and patient education or usual care. Alongside this, a health-economic study and a process-evaluation study will be conducted.

Conditions

• Hip Dysplasia

Interventions

OTHER

Exercise and patient education

Over a period of 6-months, patients will be offered eight one-to-one supervised training sessions. In these sessions, patients will be instructed in a home-based exercise programme and given patient education. The programme includes four exercises covering strength and stability training. The exercises will be performed in sets of three with a minimum of 5 repetitions, and patients will be instructed to perform a minimum of three training sessions each week. Each of the exercises can be progressed through three levels of difficulty, allowing for individualised treatment with regard to exercise quality and perceived exertion according to the Borg CR10 scale. Exercises will be performed on a perceived exertion level from somewhat hard (level 5) to very hard (level 7). Patient education includes pain management, a focus on exercise adherence and progression, and advice on physical activity.

OTHER

Usual Care

Patients will follow usual care, including an individual consultation on self-management of hip symptoms and general advice on exercise and physical activity.

Sponsors & Collaborators

• Research Unit for General Practice, Aarhus University

  collaborator OTHER

• VIA University College

  collaborator OTHER

• Copenhagen University Hospital, Hvidovre

  collaborator OTHER

• Defactum, Central Denmark Region

  collaborator OTHER_GOV

• University of Aarhus

  lead OTHER

Principal Investigators

• Julie S Jacobsen, PhD · VIA University College

• Inger Mechlenburg, DMSc · Aarhus University Hospital

• Kristian Thorborg, PhD · Copenhagen University Hospital, Hvidovre

• Rasmus Ø Nielsen, PhD · University of Aarhus

• Stig S Jakobsen, PhD · Aarhus University Hospital

• Lisa G Oestergaard, PhD · Defactum, Central Denmark Region

• Kjeld Søballe, PhD · Aarhus University Hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

50 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-04-16

Primary Completion

2027-07-31

Completion

2027-12-31

Countries

• Denmark

Study Locations